# 90Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors

> **NCT02081768** · PHASE3 · RECRUITING · sponsor: **David Clarke** · enrollment: 40 (estimated)

## Conditions studied

- Cystic Tumors of the Sellar/Parasellar Region

## Interventions

- **RADIATION:** 90yttrium colloid

## Key facts

- **NCT ID:** NCT02081768
- **Lead sponsor:** David Clarke
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2014-06
- **Primary completion:** 2031-06-30
- **Final completion:** 2031-10-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02081768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02081768, "90Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02081768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*